RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone, and was named one of DARPA’s “Biotech Startups of the Future” one year after opening its operations. The company was co-founded by David D. Ho, MD (Time magazine's "Man of the Year" in 1996 and recipient of the Presidential Citizens Medal) and Yaoxing Huang, PhD, visionary scientists affiliated with the Aaron Diamond AIDS Research Center and Professors at Columbia University Medical Center. RenBio is backed by the Bill & Melinda Gates Foundation, DARPA, and a syndicate of private investors, and is headquartered at the Alexandria Center® for Life Science in New York City.
Company Details
- Employees
- 14
- Address
- 30-02 48th Ave, Suite
- Phone
- (646) 440-9411
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- renbio.com
- HQ
- Long Island City, New York
Renbio Questions
Renbio's helpline number is (646) 440-9411
Renbio's website is renbio.com
Renbio's LinkedIn profile is https://www.linkedin.com/company/renbio
Renbio has
14 employees.
View email and phone details for 14
employees at Renbio.
Renbio's industry is
Biotechnology Research
Renbio's top competitors are
Nilo Therapeutics,
Kallyope,
Bluerock Therapeutics,
Lexeo Therapeutics,
Envisagenics,
Nucleate New York,
Neptune Bio,
Ordaos Bio,
Paratus Sciences,
Aethon Therapeutics.
Renbio's categories are Biotechnology Research
